FoxO1, A2M, and TGF-β1 : three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses |
|
Author: | Cattaneo, Annamaria1,2; Cattane, Nadia2; Malpighi, Chiara2; |
Organizations: |
1Stress, Psychiatry and Immunology Laboratory, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, UK 2Biological Psychiatry Unit, IRCCS Fatebenefratelli S. Giovanni di Dio, Brescia, Italy 3Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich, Germany
4Department of Psychology and Logopedics, University of Helsinki, Helsinki, Finland
5National Institute for Health and Welfare, Helsinki, Finland 6Folkhälsan Research Centre, Helsinki, Finland 7Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland 8Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy 9Hospital for Children and Adolescents, Helsinki University Hospital and University of Helsinki, Helsinki, Finland 10PEDEGO Research Unit, Oulu University Hospital and University of Oulu, Oulu, Finland 11Helsinki Collegium for Advanced Studies, Helsinki, Finland 12Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK 13Department of Psychiatry & Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA |
Format: | article |
Version: | published version |
Access: | open |
Online Access: | PDF Full Text (PDF, 2.9 MB) |
Persistent link: | http://urn.fi/urn:nbn:fi-fe2019092029059 |
Language: | English |
Published: |
Springer Nature,
2018
|
Publish Date: | 2019-09-20 |
Description: |
AbstractTo date, gene-environment (GxE) interaction studies in depression have been limited to hypothesis-based candidate genes, since genome-wide (GWAS)-based GxE interaction studies would require enormous datasets with genetics, environmental, and clinical variables. We used a novel, cross-species and cross-tissues “omics” approach to identify genes predicting depression in response to stress in GxE interactions. We integrated the transcriptome and miRNome profiles from the hippocampus of adult rats exposed to prenatal stress (PNS) with transcriptome data obtained from blood mRNA of adult humans exposed to early life trauma, using a stringent statistical analyses pathway. Network analysis of the integrated gene lists identified the Forkhead box protein O1 (FoxO1), Alpha-2-Macroglobulin (A2M), and Transforming Growth Factor Beta 1 (TGF-β1) as candidates to be tested for GxE interactions, in two GWAS samples of adults either with a range of childhood traumatic experiences (Grady Study Project, Atlanta, USA) or with separation from parents in childhood only (Helsinki Birth Cohort Study, Finland). After correction for multiple testing, a meta-analysis across both samples confirmed six FoxO1 SNPs showing significant GxE interactions with early life emotional stress in predicting depressive symptoms. Moreover, in vitro experiments in a human hippocampal progenitor cell line confirmed a functional role of FoxO1 in stress responsivity. In secondary analyses, A2M and TGF-β1 showed significant GxE interactions with emotional, physical, and sexual abuse in the Grady Study. We therefore provide a successful ‘hypothesis-free’ approach for the identification and prioritization of candidate genes for GxE interaction studies that can be investigated in GWAS datasets. see all
|
Series: |
Molecular psychiatry |
ISSN: | 1359-4184 |
ISSN-E: | 1476-5578 |
ISSN-L: | 1359-4184 |
Volume: | 23 |
Issue: | 11 |
Pages: | 2192 - 2208 |
DOI: | 10.1038/s41380-017-0002-4 |
OADOI: | https://oadoi.org/10.1038/s41380-017-0002-4 |
Type of Publication: |
A1 Journal article – refereed |
Field of Science: |
3142 Public health care science, environmental and occupational health |
Subjects: | |
Funding: |
Professor C.M.P. has received research funding from Johnson & Johnson as part of a program of research on depression and inflammation. In addition, Professor C.M.P. has received research funding from the Medical Research Council (UK) and the Wellcome Trust for research on depression and inflammation as part of two large consortia that also include Johnson & Johnson, GSK, Pfizer and Lundbeck. Prof. M.A.R. has received compensation as speaker/consultant for Lundbeck, Otzuka, Sumitomo Dainippon Pharma and Sunovion, and he has received research grants from Lundbeck, Sumitomo Dainippon Pharma and Sunovion, although none of these had a role in the present study. The remaining authors declare that they have no conflict of interest. |
Copyright information: |
© The Authors 2017. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |